DrKSA
All events
OncologyConference1 CME hours

International Conference on Oncology, Cancer Research and Policy (ICOCRP-27)

Organised by AFTER
Date3–4 Apr · 09:00 – 17:00
VenueRiyadh , Saudi Arabia.
AccreditationSCFHS · 1 hrs
International Conference on Oncology, Cancer Research and Policy (ICOCRP-27)
View full poster

About the event

• Oncology Policy and Healthcare Systems: Analyzing global health policy models, regulatory frameworks, and strategies to improve patient access to oncology care systems. • Impact of Legislation on Cancer Care: Understanding how regional and international healthcare laws shape clinical trial authorizations, drug approval processes, and delivery standards. • Research Funding for Cancer Initiatives: Insights into public and private grant applications, institutional funding structures, and allocating resources for impactful cancer research. • Advancements in Cancer Biology: Investigating the cellular mechanisms driving tumorigenesis, tumor microenvironments, and mutation mapping. • Innovations in Cancer Treatment: Exploring breakthroughs in targeted therapies, combination chemotherapies, and advanced surgical or radiation oncology techniques. • Precision Medicine & Biomarkers: Practical methodologies for using genetic profiling, custom patient tracking, and novel biological indicators for early-stage screening. • Immunotherapy Current Trends: Evaluating the evolving clinical landscape of immune checkpoint inhibitors, cellular therapies (like CAR-T), and cancer vaccine development

Agenda and speakers are for members

Log in or create a free account to see the agenda and speakers, and to register.

AccreditationSCFHS · 1 hours
Target audience• Healthcare Policy Makers & Legislators: Government officials, health ministry representatives, and regulatory body members who design cancer care frameworks and drug approval guidelines. • Oncologists & Clinical Practitioners: Medical, surgical, and radiation oncologists who want to align their daily clinical practices with emerging institutional policies and care standards. • Cancer Researchers & Laboratory Scientists: Biologists and geneticists seeking to understand how their laboratory discoveries influence public health funding, grants, and clinical trials. • Public Health Experts & Epidemiologists: Professionals tracking global cancer trends, screening efficacy, and resource distribution across diverse populations. • Hospital Administrators & Healthcare Leaders: Executives managing oncology wards, cancer centers, and healthcare budgets who need to adapt to evolving health policies. • Advocacy Groups & Patient Representatives: Non-profit leaders and patient advocates working to bridge the gap between scientific breakthroughs, legislative support, and patient access.

Members go straight to the organiser’s registration page.

SAR 5,200